Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Wit, J. Stewart (2004)
Reinstatement of cocaine-reinforced responding in the ratPsychopharmacology, 75
Mario Stelt, V. Marzo (2003)
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.European journal of pharmacology, 480 1-3
L. Fattore, M. Spano, G. Cossu, S. Deiana, W. Fratta (2003)
Cannabinoid mechanism in reinstatement of heroin‐seeking after a long period of abstinence in ratsEuropean Journal of Neuroscience, 17
T. Vries, A. Schoffelmeer, R. Binnekade, L. Vanderschuren (1999)
Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administrationPsychopharmacology, 143
A. Hoffman, C. Lupica (2001)
Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.Journal of neurophysiology, 85 1
J. Jaffe, N. Cascella, K. Kumor, M. Sherer (2004)
Cocaine-induced cocaine cravingPsychopharmacology, 97
D. Braida, Morena Pozzi, R. Cavallini, M. Sala (2001)
Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid systemNeuroscience, 104
R. Wise, A. Murray, M. Bozarth (2005)
Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in ratsPsychopharmacology, 100
T. Rubino, P. Massi, D. Vigano', D. Fuzio, D. Parolaro (2000)
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome.Life sciences, 66 22
Jeffrey Grimm, R. See (2000)
Dissociation of Primary and Secondary Reward-Relevant Limbic Nuclei in an Animal Model of RelapseNeuropsychopharmacology, 22
J. Stewart, H. Wit (1987)
Reinstatement of Drug-Taking Behavior as a Method of Assessing Incentive Motivational Properties of Drugs
S. Schenk, B. Partridge (1999)
Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in ratsPsychopharmacology, 147
C. Fimiani, T. Liberty, Andrew Aquirre, I. Amin, Nabil Ali, G. Stefano (1999)
Opiate, cannabinoid, and eicosanoid signaling converges on common intracellular pathways nitric oxide coupling.Prostaglandins & other lipid mediators, 57 1
M. Diana, M. Melis, A. Muntoni, G. Gessa (1998)
Mesolimbic dopaminergic decline after cannabinoid withdrawal.Proceedings of the National Academy of Sciences of the United States of America, 95 17
THORAT THORAT, BHARGAVA BHARGAVA (1994)
Evidence for a bidirectional cross‐tolerance morphine and Δ 9 ‐tetrahydrocannabinol in miceEur. J. Pharmacol., 260
M. Mascia, M. Obinu, C. Ledent, Marc Parmentier, G. Böhme, Assunta Imperato, Walter Fratta (1999)
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice.European journal of pharmacology, 383 3
H. Wit, J. Stewart (2004)
Drug reinstatement of heroin-reinforced responding in the ratPsychopharmacology, 79
L. Fattore, M. Martellotta, G. Cossu, M. Mascia, W. Fratta (1999)
CB1 cannabinoid receptor agonist WIN 55, 212-2 decreases intravenous cocaine self-administration in ratsBehavioural Brain Research, 104
R. Hampson, J. Mu, Sam Deadwyler (2000)
Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons.Journal of neurophysiology, 84 5
L. Fattore, G. Cossu, Cristina Martellotta, W. Fratta (2001)
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in ratsPsychopharmacology, 156
P. Massi, A. Vaccani, T. Rubino, D. Parolaro (2003)
Cannabinoids and opioids share cAMP pathway in rat splenocytesJournal of Neuroimmunology, 145
G. Cossu, C. Ledent, L. Fattore, A. Imperato, G. Böhme, M. Parmentier, W. Fratta (2001)
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuseBehavioural Brain Research, 118
L. Fattore, G. Cossu, M. Mascia, M. Obinu, C. Ledent, M. Parmentier, A. Imperato, G. Böhme, W. Fratta (2000)
Role of Cannabinoid CB1 Receptor in Morphine Rewarding Effects in MicePharmacy and Pharmacology Communications, 6
T. Rubino, L. Tizzoni, D. Vigano', P. Massi, D. Parolaro (1997)
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentNeuroReport, 8
Y. Shaham, U. Shalev, Lin Lu, H. Wit, J. Stewart (2003)
The reinstatement model of drug relapse: history, methodology and major findingsPsychopharmacology, 168
CHIAMULERA (1996)
Nicotine reinstatement of nicotine self-administration after long-term extinctionPsychopharmacology, 127
S. González, J. Fernández-Ruiz, V. Marzo, Mariluz Hernández, C. Arévalo, Cristina Nicanor, M. Cascio, E. Ambrosio, J. Ramos (2004)
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.Drug and alcohol dependence, 74 2
M. Solinas, L. Panlilio, Steven Goldberg (2004)
Exposure to Δ-9-Tetrahydrocannabinol (THC) Increases Subsequent Heroin Taking but not Heroin's Reinforcing Efficacy: A Self-Administration Study in RatsNeuropsychopharmacology, 29
O. Valverde, F. Noble, F. Beslot, V. Daugé, M. Fournie-Zaluski, B. Roques (2001)
Δ9‐tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effectEuropean Journal of Neuroscience, 13
Christine Duarte, R. Alonso, N. Bichet, C. Cohen, P. Soubrié, M. Thiébot (2004)
Blockade by the Cannabinoid CB1 Receptor Antagonist, Rimonabant (SR141716), of the Potentiation by Quinelorane of Food-Primed Reinstatement of Food-Seeking BehaviorNeuropsychopharmacology, 29
S. Thorat, H. Bhargava (1994)
Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice.European journal of pharmacology, 260 1
B. Szabo, T. Müller, H. Koch (1999)
Effects of Cannabinoids on Dopamine Release in the Corpus Striatum and the Nucleus Accumbens In VitroJournal of Neurochemistry, 73
T. Vries, A. Schoffelmeer, R. Binnekade, A. Mulder, L. Vanderschuren (1998)
Drug‐induced reinstatement of heroin‐ and cocaine‐seeking behaviour following long‐term extinction is associated with expression of behavioural sensitizationEuropean Journal of Neuroscience, 10
T. Vries, J. Homberg, R. Binnekade, H. Raasø, A. Schoffelmeer (2003)
Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in ratsPsychopharmacology, 168
M. Navarro, J. Chowen, M. Carrera, I. Arco, M. Villanúa, Yolanda Martin, A. Roberts, G. Koob, F. Fonseca (1998)
CB1 cannabinoid receptor antagonist‐induced opiate withdrawal in morphine‐dependent ratsNeuroReport, 9
S. Vlachou, G. Nomikos, G. Panagis (2003)
WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulationBehavioural Brain Research, 141
J. Manzanares, J. Corchero, J. Romero, J. Fernández-Ruiz, J. Ramos, J. Fuentes (1999)
Pharmacological and biochemical interactions between opioids and cannabinoids.Trends in pharmacological sciences, 20 7
(1999)
A common neurobiological mechanism regulates cannabinoid and opioid rewarding effects in mice
U. Shalev, Jeffrey Grimm, Y. Shaham (2002)
Neurobiology of Relapse to Heroin and Cocaine Seeking: A ReviewPharmacological Reviews, 54
J. Weeks (1972)
Chapter 6 – Long-term Intravenous Infusion
D. Vigano', M. Cascio, T. Rubino, F. Fezza, A. Vaccani, V. Marzo, D. Parolaro (2003)
Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat BrainNeuropsychopharmacology, 28
J. Manzanares, J. Corchero, J. Romero, J. Fernández-Ruiz, J. Ramos, J. Fuentes (1998)
Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain.Brain research. Molecular brain research, 55 1
Y. Shaham, H. Rajabi, J. Stewart (1996)
Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal, 16
S. González, M. Cascio, J. Fernández-Ruiz, F. Fezza, V. Marzo, J. Ramos (2002)
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaineBrain Research, 954
M. Navarro, M. Carrera, W. Fratta, O. Valverde, G. Cossu, L. Fattore, J. Chowen, R. Gómez, I. Arco, M. Villanúa, R. Maldonado, G. Koob, F. Fonseca (2001)
Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-AdministrationThe Journal of Neuroscience, 21
C. Ledent, O. Valverde, G. Cossu, F. Petitet, J. Aubert, F. Beslot, G. Böhme, A. Imperato, T. Pedrazzini, B. Roques, G. Vassart, W. Fratta, M. Parmentier (1999)
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.Science, 283 5400
G. Tanda, F. Pontieri, G. Chiara (1997)
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.Science, 276 5321
T. Vries, Y. Shaham, J. Homberg, H. Crombag, K. Schuurman, Jeanine Dieben, L. Vanderschuren, A. Schoffelmeer (2001)
A cannabinoid mechanism in relapse to cocaine seekingNature Medicine, 7
(2002)
Functional interaction between cannabinoids and opioids in animal models of drug addiction, Proceedings of the ‘Frontiers in Addiction Research
A. Markou, F. Weiss, L. Gold, S. Caine, G. Schulteis, G. Koob (2005)
Animal models of drug cravingPsychopharmacology, 112
W. Hunt, L. Barnett, L. Branch (1971)
Relapse rates in addiction programs.Journal of clinical psychology, 27 4
(2001)
VANDERSCHUREN, L.J.M.J. & SCHOFFELMEER, A.N.M
S. González, J. Fernández-Ruiz, Valentina Sparpaglione, D. Parolaro, J. Ramos (2002)
Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.Drug and alcohol dependence, 66 1
M. Navarro, J. Fernández-Ruiz, R. Miguel, M. Hernández, M. Cebeira, J. Ramos (1993)
An acute dose of δ9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activityBehavioural Brain Research, 57
Lin Lu, Jack Shepard, F. Hall, Y. Shaham (2003)
Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a reviewNeuroscience & Biobehavioral Reviews, 27
D. Centonze, N. Battista, S. Rossi, N. Mercuri, A. Finazzi-Agrò, G. Bernardi, P. Calabresi, M. Maccarrone (2004)
A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic TransmissionNeuropsychopharmacology, 29
M. Shapira, Z. Vogel, Y. Sarne (2000)
Opioid and Cannabinoid Receptors Share a Common Pool of GTP-Binding Proteins in Cotransfected Cells, But Not in Cells Which Endogenously Coexpress the ReceptorsCellular and Molecular Neurobiology, 20
G. Tanda, P. Munzar, S. Goldberg (2000)
Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeysNature Neuroscience, 3
Charles O'Brien (1997)
A range of research-based pharmacotherapies for addiction.Science, 278 5335
M. Solinas, L. Panlilio, K. Antoniou, L. Pappas, S. Goldberg (2003)
The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in RatsJournal of Pharmacology and Experimental Therapeutics, 306
E. Gardner, W. Paredes, D. Smith, A. Donner, C. Milling, D. Cohen, D. Morrison (2006)
Facilitation of brain stimulation reward byΔ9-tetrahydrocannabinolPsychopharmacology, 96
M. Shapira, M. Gafni, Y. Sarne (2003)
Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulationBrain Research, 960
D. Carriero, J. Aberman, Sonyan Lin, Adam Hill, Alexandros Makriyannis, J. Salamone (1998)
A detailed characterization of the effects of four cannabinoid agonists on operant lever pressingPsychopharmacology, 137
We recently provided evidence for a functional link between cannabinoid and opioid endogenous systems in relapse to heroin‐seeking behaviour in rats. In the present study, we aimed at investigating whether the previously observed cross‐talk between cannabinoids and opioids could be extended to mechanisms underlying relapse to cannabinoid‐seeking behaviour after a prolonged period of abstinence. In rats previously trained to intravenously self‐administer the synthetic cannabinoid receptor (CB1) agonist WIN 55,212‐2 (12.5 μg kg−1 inf−1) under a fixed ratio (FR1) schedule of reinforcement, noncontingent nonreinforced intraperitoneal (i.p.) priming injections of the previously self‐administered CB1 agonist (0.25 and 0.5 mg kg−1) as well as heroin (0.5 mg kg−1), but not cocaine (10 mg kg−1), effectively reinstate cannabinoid‐seeking behaviour following 3 weeks of extinction. The selective CB1 receptor antagonist SR 141716A (0.3 mg kg−1 i.p.) does not reinstate responding when given alone, but completely prevents the cannabinoid‐seeking behaviour triggered by WIN 55,212‐2 or heroin primings. The nonselective opioid antagonist naloxone (1 mg kg−1 i.p.) has no effect on operant behaviour per sè, but significantly blocks cannabinoid‐ and heroin‐induced reinstatement of cannabinoid‐seeking behaviour. These results provide the first evidence of drug‐induced reinstatement of cannabinoid‐seeking behaviour, and further strengthen previous findings on a cross‐talk between the endogenous cannabinoid and opioid systems in relapse mechanisms to drug‐seeking. British Journal of Pharmacology (2004) 143, 343–350. doi:10.1038/sj.bjp.0705932
British Journal of Pharmacology – Wiley
Published: Oct 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.